Mohan Arti, Gundamaraju Rohit
Department of Pharmacolgy, Malla Reddy Institute of Pharmaceutical Sciences, Maisammaguda, Secunderabad, Hyderabad, Andhra Pradesh, India.
Int J Pharm Investig. 2015 Jan-Mar;5(1):57-64. doi: 10.4103/2230-973X.147235.
Investigation of in vitro/in vivo behavior of fast-dissolving tablets containing solid dispersions (SDs) of lamotrigine (LM) was the aim and focus of the present research work.
The effect of various hydrophilic polymers on the aqueous solubility of LM was studied. Polyethylene glycol (PEG 6000) was selected as the vehicle and SDs were prepared by melting and solvent evaporation method (SEM). Evaluation of SD for dissolution indicated SVM was more appropriate as seen from an enhancement in drug dissolution. Infrared spectroscopy, differential scanning calorimetry, and powder X-ray diffraction studies indicated a lack of physicochemical interaction between the drug and the carrier. A total of nine formulations were compressed into fast-dissolving tablets using Avicel pH 102 as a directly compressible filler and ac-di-sol, sodium starch glycolate and crospovidone as super disintegrates and evaluated for pre- and post-compression parameters and in vitro drug release.
Mathematical analysis of in vitro data suggested that first order was most suitable mathematical model for describing the optimized formulation. Stability studies indicated that the effect of storage was insignificant at 5% level of confidence. In vivo studies of pure drug, selected formulation and marketed product were carried out in male Wistar rats and pharmacokinetic (PK) parameters were calculated using PK function for Microsoft Excel. The best formulation has shown Tmax of 0.5 h which was highly significant (P < 0.05) when compared with pure drug and marketed formulation. The statistical significance was assessed by one way analysis of variance.
Therefore, the SDs prepared by SEM using PEG 6000 as hydrophilic carrier can be successfully used for improvement of dissolution of LM and resulted in faster onset of action as indicated by in vivo studies.
研究含拉莫三嗪(LM)固体分散体(SDs)的速溶片的体外/体内行为是本研究工作的目的和重点。
研究了各种亲水性聚合物对LM水溶性的影响。选择聚乙二醇(PEG 6000)作为载体,采用熔融和溶剂蒸发法(SEM)制备SDs。从药物溶出度的提高来看,SDs的溶出度评价表明SVM更合适。红外光谱、差示扫描量热法和粉末X射线衍射研究表明药物与载体之间缺乏物理化学相互作用。使用微晶纤维素pH 102作为直接压片填充剂,将总共九种制剂压制成速溶片,并使用交联羧甲基纤维素钠、淀粉乙醇酸钠和交联聚维酮作为超级崩解剂,对压片前后的参数和体外药物释放进行评价。
体外数据的数学分析表明,一级模型是描述优化制剂最合适的数学模型。稳定性研究表明,在5%置信水平下,储存的影响不显著。在雄性Wistar大鼠中进行了纯药物、选定制剂和市售产品的体内研究,并使用Microsoft Excel的PK函数计算了药代动力学(PK)参数。最佳制剂的Tmax为0.5小时,与纯药物和市售制剂相比具有高度显著性(P < 0.05)。通过单因素方差分析评估统计学显著性。
因此,以PEG 6000为亲水性载体通过SEM制备的SDs可成功用于改善LM的溶出度,并如体内研究所表明的那样导致更快的起效。